University of Wisconsin–Madison

Sean Ronnekleiv-Kelly, MD

Assistant Professor

  • Endowed Professor, Ronald E. and Patricia A. Kissinger Surgical Oncology Research Professorship 
  • Division of Surgical Oncology
(608) 262-2025

600 Highland Ave
BX 7375
K4/757 CSC
Madison, WI 53792


  • MD, University of Colorado School of Medicine, 2008
  • General Surgery Residency, University of Wisconsin School of Medicine and Public Health, 2015
  • Complex General Surgical Oncology Fellowship, Johns Hopkins Hospital, 2017

Clinical Specialties

Certified by the American Board of Surgery in General Surgery and specializes in malignant disease of the pancreas, liver, gallbladder and biliary tree, stomach and small intestine, neuroendocrine tumors and retroperitoneal sarcoma.

Research Interests

Principal research interest is pancreatic cancer. My lab focuses on formation and progression of pancreatic cancer as well as understanding communication within the tumor microenvironment.

Recent Publications

    • Evaluating the ACS NSQIP Risk Calculator in Primary Pancreatic Neuroendocrine Tumor: Results from the US Neuroendocrine Tumor Study Group.
    • Dave A, Beal EW, Lopez-Aguiar AG, Poultsides G, Makris E, Rocha FG, Kanji Z, Ronnekleiv-Kelly S, Rendell VR, Fields RC, Krasnick BA, Idrees K, Smith PM, Nathan H, Beems M, Maithel SK, Pawlik TM, Schmidt CR, Dillhoff ME
    • J. Gastrointest. Surg. 2019 Apr 02;
    • [PubMed ID: 30941685]
    • Autoimmune Diseases of the Biliary Tract: A Review.
    • Lee CW, Ronnekleiv-Kelly S
    • Surg. Clin. North Am. 2019 Apr; 99(2): 185-201
    • [PubMed ID: 30846029]
    • Natural History and Treatment Trends in Pancreatic Cancer Subtypes.
    • Pokrzywa CJ, Abbott DE, Matkowskyj KA, Ronnekleiv-Kelly SM, Winslow ER, Weber SM, Fisher AV
    • J. Gastrointest. Surg. 2019 Apr; 23(4): 768-778
    • [PubMed ID: 30706376]
    • Analysis of 90-day cost for open versus minimally invasive distal pancreatectomy.
    • Fisher AV, Fernandes-Taylor S, Schumacher JR, Havlena JA, Wang X, Lawson EH, Ronnekleiv-Kelly SM, Winslow ER, Weber SM, Abbott DE
    • HPB (Oxford) 2019 Jan; 21(1): 60-66
    • [PubMed ID: 30076011]
    • The Impact of Hospital Neoadjuvant Therapy Utilization on Survival Outcomes for Pancreatic Cancer.
    • Fisher AV, Abbott DE, Venkatesh M, Leverson GE, Campbell-Flohr SA, Ronnekleiv-Kelly SM, Greenberg CC, Winslow ER, Weber SM
    • Ann. Surg. Oncol. 2018 Sep; 25(9): 2661-2668
    • [PubMed ID: 30003452]

All Publications on PubMed